Eye scan study for newly diagnosed wet AMD
Part of Eyes & vision clinical trials.
This study uses a special eye scan (OCT angiography) to look at new, abnormal blood vessel growth in people with wet age-related macular degeneration (wet AMD) who have not been treated yet. It may help researchers better understand the disease and how it changes over time.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be age 50 or older and have newly diagnosed wet AMD with active new blood vessel growth
- You have not had treatment for wet AMD before (treatment-naïve)
- You can give informed consent and share your eye/health details
- Your blood pressure is not higher than 180/110
- You have not had macular laser treatment before
- Your eyesight is 20/200 or better, and you can hold still for the scan
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses detailed eye imaging (an eye scan) to look for signs related to probable Alzheimer’s disease and mild dementia. It may help researchers understand whether eye scans can reflect brain changes and improve detection.
This study uses a detailed eye scan (optical coherence tomography angiography) to look at how blood vessels in the retina are affected. It may help researchers better understand retinal vascular diseases, though some people will be excluded for safety or image-quality reasons.
This study uses an OCT scan, a painless imaging test, to look for early signs of diabetic retinopathy (damage to the retina caused by diabetes) in people who have no symptoms. It aims to detect problems early so they can be managed before vision is affected.
This study compares two types of eye scan machines to see which one is better at detecting abnormal blood vessels in people with a specific eye condition called pigment epithelium detachment, which is related to age-related macular degeneration.
This study uses specialized eye imaging to track changes in geographic atrophy, a type of vision loss from macular degeneration. Researchers will use new imaging techniques to better understand how this condition progresses and how treatments work.
This study uses special eye scans and tests to look for blood vessel problems that may be linked to dry age-related macular degeneration (AMD). It might help find new ways to treat the condition.
Hear when a new Neovascular (Wet) Age-related Macular Degeneration (AMD) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.